Sage Therapeutics Inc (NASDAQ:SAGE) price on Friday, June 13, rose 1.52% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $6.70.
A look at the stock’s price movement, the close in the last trading session was $6.60. Turning to its 52-week performance, $13.47 and $4.62 were the 52-week high and 52-week low respectively. Overall, SAGE moved 5.02% over the past month.
Sage Therapeutics Inc’s market cap currently stands at around $419.56 million, with investors looking forward to this quarter’s earnings report slated for in July.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 4 analyst(s) rate the stock as a Hold, 3 recommend SAGE as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SAGE’s current price about -0.15% and -3.86% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.26, while 7-day volatility ratio is 2.89% and 2.36% in the 30-day chart. Further, Sage Therapeutics Inc (SAGE) has a beta value of 0.18, and an average true range (ATR) of 0.28. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $5. Looking at the price targets, the low is 25.37% off current price level while to achieve the yearly target high, price needs to move 25.37%. Nonetheless, investors will most likely welcome a 25.37% jump to $5 which is the analysts’ median price.
If we refocus on Sage Therapeutics Inc (NASDAQ:SAGE), historical trading data shows that trading volumes averaged 977.57K over the past 3 months. The company’s latest data on shares outstanding shows there are 62.54 million shares.
The 12.03% of Sage Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 85.56% of the company’s shares. Current price change has pushed the stock 23.39% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SAGE stock continues to rise going into the next quarter.
